Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones +3 more
wiley +1 more source
The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs? [PDF]
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State level panel data. Improvements in medical technology are believed to be partly responsible for rapidly rising health expenditures.
Civan, Abdülkadir, Koksal, Bulent
core +1 more source
Analysis of etodolac and diclofenac in pure and pharmaceutical forms using ionic-liquid dispersive liquid–liquid microextraction and RP-HPLC technique [PDF]
R Al-Azzawi +3 more
openalex +1 more source
Pharmaceutical enterprises drug quality strategy Moran analysis considering government supervision and new media participation [PDF]
, 2023 Yanping Xu, Lilong Zhu
openalex +1 more source
Predicting Loss of Ambulation in Limb Girdle Muscular Dystrophy R9
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Limb girdle muscular dystrophy type R9 (LGMDR9) results from biallelic variants in FKRP. There is limited data to predict loss of ambulation (LOA) among those with LGMDR9. Methods Participants in an ongoing dystroglycanopathy natural history study (NCT00313677) with FKRP variants who had achieved ambulation and were more than 3 ...
Chandra L. Miller +6 more
wiley +1 more source
Reseña de: "LET THEM EAT PROZAC. THE UNHEALTHY RELATIONSHIPBETWEEN THE PHARMACEUTICAL INDUSTRY AND DEPRESSION." de David Healy [PDF]
, 2005 Alberto Ortiz Lobo
openalex
Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions [PDF]
, 2022 Simon Arsène +12 more
openalex +1 more source
Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley +1 more source
The current status of pharmaceutical care provision in tertiary hospitals: results of a cross-sectional survey in China [PDF]
, 2020 Xiaobo Guo +5 more
openalex +1 more source
Study on the Selection of Pharmaceutical E-Commerce Platform Considering Bounded Rationality under Probabilistic Hesitant Fuzzy Environment [PDF]
, 2023 Zixue Guo, Sijia Liu
openalex +1 more source